Best Synribo (Omacetaxine) Medicine in India

Synribo (Omacetaxine) is an anticancer treatment used for adults with chronic or accelerated phase chronic myeloid leukemia (CML) who have developed resistance or intolerance to two or more tyrosine kinase inhibitors (TKIs). Omacetaxine works through a mechanism that is different from TKIs, helping to reduce the production of proteins that cancer cells need to grow and survive.

Synribo (Omacetaxine) is a protein synthesis inhibitor that interferes with the production of certain proteins involved in leukemia cell survival. By reducing these proteins, it helps slow the growth and multiplication of abnormal blood cells and may help control the progression of CML.

Synribo (Omacetaxine) should be used exactly as prescribed by your doctor and is administered by subcutaneous injection according to the recommended treatment schedule. Regular blood tests are important to monitor blood cell counts and detect possible complications. Tell your doctor about any medical conditions and all medicines, vitamins, herbal products, or supplements you are taking before starting treatment.

Treatment of Chronic Myeloid Leukemia (CML)

Synribo (Omacetaxine) is used to treat adults with chronic or accelerated phase chronic myeloid leukemia (CML) whose disease has become resistant or intolerant to two or more tyrosine kinase inhibitors (TKIs). By interfering with the production of proteins that leukemia cells need for growth and survival, it helps reduce abnormal blood-cell production and may help slow the progression of CML.

Some side effects of Synribo (Omacetaxine) may improve as the body adjusts to the treatment. Consult your doctor if any side effect persists, becomes severe, or causes concern.

Common Side Effects of Synribo (Omacetaxine)

Synribo (Omacetaxine) is given as a subcutaneous injection under the skin, usually according to a treatment schedule prescribed by your doctor. It may be administered by a healthcare professional or, after appropriate training, self-administered as instructed. Follow the prescribed schedule carefully and do not change the dose or stop treatment without medical advice. Regular blood tests are important to monitor blood-cell counts and treatment response.

Synribo (Omacetaxine) works by inhibiting protein synthesis, which reduces the production of proteins that leukemia cells need to grow and survive. It can reduce levels of certain cancer-promoting proteins, including BCR-ABL-related proteins, helping to slow the growth and multiplication of abnormal blood cells in chronic myeloid leukemia (CML).

• Store the unreconstituted medicine at room temperature, below 25°C.
• Once reconstituted, keep the solution refrigerated between 2°C and 8°C and use within 12 hours.
• Protect the medicine from direct sunlight during storage.
• Keep the product in a safe place, out of the reach of children.

Alcohol CONSULT YOUR DOCTOR

Avoid or limit alcohol unless your doctor advises otherwise, as it may worsen fatigue, dizziness, or other treatment-related side effects.

Pregnancy CONSULT YOUR DOCTOR

Synribo (Omacetaxine) may harm an unborn baby. Inform your doctor if you are pregnant or planning to become pregnant. Use effective contraception during treatment as advised by your healthcare professional.

Breastfeeding CONSULT YOUR DOCTOR

Do not breastfeed during treatment with Synribo (Omacetaxine). Discuss with your doctor when it may be safe to resume breastfeeding.

Driving CONSULT YOUR DOCTOR

Synribo (Omacetaxine) may cause fatigue, weakness, dizziness, or other symptoms that can affect alertness. Avoid driving or operating machinery if you experience these effects.

Kidney CAUTION

Tell your doctor if you have kidney problems before starting treatment. Your doctor may monitor your health and laboratory results during treatment.

Liver CAUTION

Inform your doctor about any liver problems. Your doctor may monitor liver function and other blood-test results throughout treatment.

• Use Synribo (Omacetaxine) exactly as prescribed and follow the recommended injection schedule carefully.
• Attend regular blood tests so your doctor can monitor blood-cell counts and detect complications early.
• Report unusual bleeding, bruising, fever, chills, or signs of infection promptly, as treatment can lower blood-cell counts.
• Monitor your blood sugar as advised by your doctor, especially if you have diabetes or develop symptoms of high blood sugar.
• Inform your doctor about all medicines, vitamins, herbal products, and supplements you are taking, and report any severe or persistent side effects.
• Read More About - Synribo (Omacetaxine) from Pharma Five.

Pharma Five, may assist patients in arranging the import of Synribo (Omacetaxine) in small quantities for personal medical use. For this purpose, the applicant must submit an application in Form 12A along with a prescription issued by a Registered Medical Practitioner (RMP). <br>

With extensive experience in the pharmaceutical industry, Pharma Five assists patients in accessing Synribo (Omacetaxine) and other specialized medicines through professional import facilitation and related services. Pharma Five provides extensive pharmaceutical service coverage across India, serving patients and healthcare requirements in prominent cities such as Mumbai, Delhi, Kolkata, Bhubaneswar, Bangalore, Hyderabad, Chennai, Ahmedbad, Pune, Surat, Visakhapatnam, Jaipur, Lucknow, Nagpur, Indore, Patna, Agartala, Guwahati, Imphal, Kohima, Namchi, Noida, Ghaziabad, Ludhiana, Agra, Varanasi, Srinagar, Amritsar, Jodhpur, Chandigarh, Gurgaon, Gorakhpur, Dehradun, Jammu, Hyderabad, Thiruvananthapuram, Kochi, Coimbatore, Puducherry, Mysuru, Salem, Vellore, Tiruppur, Guntur, Goa, Kolhapur, Mumbai, Nashik, and various other regions in India.